Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
about
The emergence of Lyme diseaseDiagnosis of lyme borreliosis.Lyme DiseaseChronic Lyme diseaseChronic Lyme disease: a reviewLyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?Lyme borreliosis treatment.Diagnostic challenges of early Lyme disease: lessons from a community case seriesIn vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapyDecreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans.Proof that chronic lyme disease exists.Antiscience and ethical concerns associated with advocacy of Lyme disease.Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosisBill C-442: Shining the limelight on the Lyme-like?Lyme neuroborreliosis-epidemiology, diagnosis and management.Generalizability in two clinical trials of Lyme disease.Variable VlsE is critical for host reinfection by the Lyme disease spirochete.Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferiCorrelation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical FindingsAntibiotic treatment of Lyme borreliosis: what is the evidence?Lyme disease: Is it or is it not?Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Lyme disease: the quest for magic bullets.ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention.Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.Strategies for primary and secondary prevention of Lyme disease.Lyme disease and the orthopaedic implications of lyme arthritis.Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures.Management of Lyme disease.Skin manifestations of lyme borreliosis: diagnosis and management.Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study.Controversies in Persistent (Chronic) Lyme Disease.Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme diseaseSpatiotemporal evolution of erythema migrans, the hallmark rash of Lyme disease.Treatment of Lyme borreliosis.The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in BelgiumReservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.Management approaches for suspected and established Lyme disease used at the Lyme disease diagnostic center.
P2860
Q22241895-D7C28D80-7CC5-49EF-881D-52D064968CE4Q22242237-684C962F-C1AD-45BB-9E0D-074E50F4891EQ22250895-827075FD-47DA-4080-9A39-6BC7B2F391A7Q22252195-8ED181DA-31AB-4AAA-BCF5-310226B60755Q22252200-1E356BC5-3F42-4721-95A5-20F34DEFD3E1Q26795774-8404B109-BAE4-4748-B3E5-FC2D77F9B2F2Q33327161-964DF1A0-EF43-40C4-A914-07926916B87FQ33457704-41DAB5D7-2AF6-4CD5-873A-EECBACC6B703Q33722062-B60A5B81-8DD3-4878-9416-C756BAC6B63AQ33869706-21603905-BCE0-4CFD-BD0B-63833F07D23EQ33876091-946AD5E2-8C6B-49E7-977F-8ABA2225397BQ34210918-886AAA06-D367-4155-B2E4-5C537921F668Q34336214-A4CDA642-8AF1-4462-915A-C518B3F3003EQ34374899-675D0CD2-85F9-493E-86AB-50E2556CB7D7Q34413366-369922DD-90DB-4D2B-8654-9B7A6C979FD7Q34487119-832682C1-FDC0-4335-A4A8-2DE57D6C3478Q34574254-5773FD6C-B8A4-421C-98A5-F13B35A23A0BQ34674810-CFE1F5D8-7DB3-4323-A470-73413B7D19DEQ35609906-2413EA6E-D712-4ECC-A51C-4A057C4456A4Q35768062-20A7AD66-C0ED-4A9D-8CD8-F2584B123DD8Q36071885-F96BAAAA-97F1-4713-971C-2E99803CA3BAQ36170946-9659A867-BB36-46B7-9482-A45EC53510DDQ36297670-9367A31C-2F87-4818-BE41-33CCA4FEB9FBQ36404911-280357F1-22D4-4EFA-8ACE-F6D3670FFBCDQ36440274-DB60C08E-828E-4831-9145-5E35E42898D1Q36542592-270E7BE4-EB87-4CCF-A7E7-73B3D1A6E6E3Q36679488-27DD9CFD-A89F-41BF-8861-0B151A6F6266Q36699047-8198D4DD-5530-4BE2-AE3C-6CBC4C9382BDQ36850934-585732FF-BC57-44ED-B21A-463E2BECDB8DQ36948131-273E7B48-CDEB-42BC-8653-A386F7E524F3Q37124900-1667EBC8-7637-4405-AA2B-066E8138586DQ37313420-D35C253D-5741-4407-8792-0567CD7F1D0BQ37403952-B9D1E3D4-7985-439E-82BB-D158BC65593BQ37403994-A6BD3C45-A879-4BD0-B46A-BEBA948826DAQ37419565-464FED75-7132-45A7-9B29-8F354B9DEF2EQ37621775-FAED324E-BAB1-4E59-B72C-9F47E9A51371Q37672670-DB913898-6C3E-497F-8BF7-C51FE165BEC2Q38631380-02CA2183-0D18-4455-B5A5-B0FBC5B47BF3Q38955013-4C58BA0D-3170-42D9-82B3-AF0B751C9C50Q40122826-BA5F0F1B-1662-49BE-BB53-C03150792B1B
P2860
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Duration of antibiotic therapy ...... ind, placebo-controlled trial.
@en
Duration of antibiotic therapy ...... ind, placebo-controlled trial.
@nl
type
label
Duration of antibiotic therapy ...... ind, placebo-controlled trial.
@en
Duration of antibiotic therapy ...... ind, placebo-controlled trial.
@nl
prefLabel
Duration of antibiotic therapy ...... ind, placebo-controlled trial.
@en
Duration of antibiotic therapy ...... ind, placebo-controlled trial.
@nl
P2093
P1476
Duration of antibiotic therapy ...... ind, placebo-controlled trial.
@en
P2093
Brij Singh
Diane Holmgren
Donna McKenna
Gary P Wormser
John Nowakowski
Paul Visintainer
Rhea Dornbush
Robert B Nadelman
Roshan Ramanathan
P304
P356
10.7326/0003-4819-138-9-200305060-00005
P407
P577
2003-05-01T00:00:00Z